Stay updated on Efgartigimod in ITP Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod in ITP Clinical Trial page.

Latest updates to the Efgartigimod in ITP Clinical Trial page
- Check6 days agoChange DetectedThe page history now shows an added Revision: v3.3.4 and a removed Revision: v3.3.3, indicating a minor maintenance update to the release notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe version history now includes a new revision tag: Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed from the page footer, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2. No changes to study data or navigation are evident.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved the banner notice about government funding and operating status from the page header. The change affects only a site-wide status message, not trial data or navigation.SummaryDifference0.5%

- Check77 days agoChange DetectedThe new screenshot shows small UI tweaks to the Record History page, including spacing and label adjustments, with the core list of study record versions remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check106 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference11%

Stay in the know with updates to Efgartigimod in ITP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod in ITP Clinical Trial page.